Oral Presentation Australian Diabetes Society and the Australian Diabetes Educators Association Annual Scientific Meeting 2017

Glycaemic outcomes of nurse led insulin dose adjustment clinic (#52)

Katherine A Worton 1 , Cecile A Eigenmann 1 , Penny E Morris 1 , Hayley K Patterson 1 , Leanne C Gregory 1 , Liam J Collins 1 , Jerry R Greenfield 2 , Joanne E Taylor 1
  1. St. Vincents Hospital Diabetes Centre, Darlinghurst, NSW, Australia
  2. Department of Endocrinology, St. Vincent"s Hospital, Sydney, NSW, Australia

Introduction: St Vincent’s Hospital (Sydney) Diabetes Centre has delivered an insulin dose titration program since 1979. The IDA Clinic is a core part of the Diabetes Centre’s activity operated by a Diabetes Nurse Educator (DNE) Monday to Friday from 8am to 12 midday.  The benefit of this clinic to patient glycaemic outcomes had not been established.

Objective: To determine whether participation in the IDA clinic improves glycaemic outcomes.

Methods: All patients enrolled in the IDA Clinic from 13 April to 12 October 2016 (26 weeks) were audited. The following data was collected on all enrolled patients: age, diabetes type, enrolment date, discharge date, HbA1c pre-enrolment and ≤ 6 months post-discharge and whether patient achieved target BGLs. 

Results: We enrolled 172 patients.  Mean age was 59 y (range 18-91). Seventy-two percent (n=123) had type 2 diabetes, 22% (n=38) had type 1 diabetes, 4% (n=7) had steroid-induced diabetes and 2% (n=4) had other diabetes.  Average length of stay in the clinic was 9 weeks (range 0-28).  Of those enrolled, 109 had pre- and post-clinic HbA1c data available.  Of these, 69% (n = 75) completed the programme (determined by achieving target blood glucose levels).

As shown in the table, there was a significant improvement in glycaemic control (1.3% reduction in HbA1c) after participation in the IDA Clinic (P<0.001). There was a significantly greater improvement in HbA1c in completers versus non-completers (P=0.02).

 

Mean HbA1c % (mmol/mol) pre-enrolment

Range

Mean HbA1c % (mmol/mol) post-discharge

Range

P-value

All patients

(n=109)

9.4

(79)

6.3-16.7

(45-159)

8.1

(65)

5.0-11.3

(31-100)

P<0.001

Completers

(n=75)

9.5

(80)

6.3-15.6

(45-147)

7.9

(63)

5.0-11.3

(31-100)

P<0.001

Non-completers

(n=34)

9.2

(77)

6.8-16.7

(51-159)

8.5

(69)

5.9-11.1

(41-98)

P=0.05

Conclusion: Enrolment in an insulin dose adjustment program improves glycaemic control in the short-term.  Future analysis will determine whether this benefit is maintained.